The impact of implementation of the Bethesda system for reporting thyroid cytopathology on the surgical treatment of thyroid nodules

American Surgeon

Volumn 78, Issue 6, 2012, Pages 706-710

  Richmond, Bryan K ^a   O'Brien, Bridget A ^a   Mangano, William ^b   Thompson, Stephanie ^b   Kemper, Suzanne ^b  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b CHARLESTON AREA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BETHESDA SYSTEM FOR REPORTING THYROID CYTOPATHOLOGY; CANCER CLASSIFICATION; DIAGNOSTIC ACCURACY; FEMALE; HASHIMOTO DISEASE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; NODULAR GOITER; RETROSPECTIVE STUDY; STANDARDIZATION; THYROID FOLLICULAR CARCINOMA; THYROID NODULE; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; THYROID NODULE; THYROIDECTOMY; YOUNG ADULT;

EID: 84863091022     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Vander J, Gaston E, Dawber T. The significance of nontoxic thyroid nodules: final report of a 15-year study of the incidence of thyroid malignancy. Ann Intern Med 1968;69:537-40.
2. Rojeski M, Gharib H. Nodular thyroid disease. Evaluation and management. N Engl J Med 1985;313:428-36. (Pubitemid 15014039)
3. Mazzaferri E. Thyroid cancer in thyroid nodules: finding a needle in the haystack. Am J Med 1992;93:359-62.
4. Coper D, Doherty G, Haugen B, et al. Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1167-214.
5. Rabaglia J, Kabbani W, Wallace L, et al. Effect of the Bethesda system for reporting thyroid cytopathology on thyroidectomy rates and malignancy risk in cytologically indeterminate lesions. Surgery 2010;148:1267-73.
6. Cibas E, Ali S. The Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol 2009;132:658-65.
7. Jo V, Stelow E, Dustin S, Hanley K. Malignancy risk for fine needle aspiration of thyroid lesions according to the Bethesda system for reporting thyroid ctyopathology. Am J Clin Pathol 2010;134:450-6.
8. Theoharis C, Schofield K, Hammers L, et al. The Bethesda thyroid fine needle aspiration classification system: year 1 at an academic institution. Thyroi 2009;19:1215-23.
9. Crowe A, Linder A, Hameed O, et al. The impact of implementation of the Bethesda system for reporting thyroid cytopathology on the quality of reporting, risk of malignancy, surgical rate, and rate of frozen sections requested for thyroid lesions. Cancer Cytopathology 2011;119:315-21.